INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 March 2012
Total net assets |
£118.8m |
NAV per share |
214.3p |
Share price |
183.5p |
Total value of unquoted investments |
£19.0m |
Total number of portfolio companies |
66 |
Cash |
9% NAV |
Cash committed and reserved to unquoted investments |
(8)% NAV |
Portfolio companies with < 1 year of cash |
8.18% NAV |
Top Ten Holdings
Company Name |
% NAV |
Celgene Amgen |
4.8 4.7 |
Pharmaxis Teva |
4.0 3.9 |
Alexion |
3.8 |
Insulet |
3.5 |
Biogen Gilead Aptiv Solutions |
3.3 2.9 2.7 |
Illumina |
2.6 |
|
----------- |
Total |
36.2 |
Geographical Allocation |
% |
United States & Canada |
70 |
Europe |
13 |
Australia |
4 |
Israel |
4 |
Cash |
9 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
75 |
Unquoted |
16 |
Cash |
9 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
19 APRIL 2012